Bone Health Assessment in Men on Androgen Deprivation Therapy for Prostate Cancer: A Nurse Practitioner-Led Quality Improvement Protocol
Identification:
unj_nd19_02
Issue:
November-December 2019
Volume:
Volume 39 Number 6
Credits(Post Test and/or Evaluation Required) Available until 12/31/2021
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Faculty, Planners and Authors Conflict of Interest Disclosure: The author(s), editor, editorial board, content reviewers, and education director reported no actual or potential conflict of interest in relation to this continuing nursing education article. Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Accreditation Statement: This educational activity is provided by the Society of Urologic Nurses and Associates (SUNA).
The Society of Urologic Nurses and Associates (SUNA) is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.
SUNA is a provider approved by the California Board of Registered Nursing, Provider Number CEP 5556.
This article was reviewed and formatted for contact hour credit by Michele Boyd, MSN, RN-BC, SUNA Education Director.
Learning Outcome: After completing this learning activity, the learner will be able to discuss how a Nurse Practitioner-led QI protocol facilitated consistency in providing evidence-based practice related to bone health screening, education and treatment for men with prostate cancer on ADT.
Learner Engagement Activity: This article emphasizes the increased risk for fracture in men who are being treated with ADT for prostate cancer. Visit the NCCN website at https://www.nccn.org/professio... to review the guidelines for prostate cancer.
You must be logged in and own this product in order to post comments.
Louise Kester
9/10/20 2:00 pm
I read this article. Found the information relevant to our practice. As a staff nurse I given a fair amount of ADT injections to our prostate cancer patient. Spoke with one of our lead MD's who does a lot of CA Tx. We discussed bone loss and treatment, he asked me to encourage the pt's to use calcium and vitamin D as the providers recommend. This is a real issue with this treatment mostly in the older population that is a bone loss, fall rise group.
Louise Kester
9/10/20 2:00 pm
I read this article. Found the information relevant to our practice. As a staff nurse I given a fair amount of ADT injections to our prostate cancer patient. Spoke with one of our lead MD's who does a lot of CA Tx. We discussed bone loss and treatment, he asked me to encourage the pt's to use calcium and vitamin D as the providers recommend. This is a real issue with this treatment mostly in the older population that is a bone loss, fall rise group.